Abstract 113: Endothelial Argonaute 1: A Novel Regulator Of Hyperlipidemia And Atherosclerosis

Z. Chen,Alonso Tapia,N. Malhi,Dongqiang Yuan,Yingjun Luo,Xuejing Liu
DOI: https://doi.org/10.1161/atvb.44.suppl_1.113
2024-05-01
Abstract:Background: Dysfunctional endothelial cells (ECs) crucially contribute to atherosclerosis (AS) largely through vascular inflammation. Beyond this, understanding the role of EC dysfunction (ECD) in liver dysfunction and hyperlipidemia, another AS driver, is unclear. Argonaute 1 (AGO1), a core protein in the RNA-induced silencing complex, was found to regulate EC response to hypoxic and metabolic stresses in our previous studies. EC conditional AGO1 knockout (EC-AGO1-KO) mice are protected from diet-induced obesity. However, the role of AGO1 in EC response to pro-atherogenic stimuli and its importance in hyperlipemia and AS are unknown. Methods: We subjected EC-AGO1-KO and wild-type mice to an AS model induced by AAV9-PCSK9 with a high-fat-high-cholesterol diet. We measured plasma lipids, liver enzymes and analyzed liver and AS lesions. In human EC cultures, AGO1 knockdown and oxPAPC challenged were performed. RNA-sequencing evaluated gene expression, and monocyte adhesion assays assessed EC function were then performed. Furthermore, we performed CUT&Tag assay to probe a non-canonical role of AGO1 in the nucleus through transcriptional modulation. Results: EC-AGO1-KO mice showed remarkable atheroprotective effects, with attenuated hyperlipidemia, improved liver function, and reduced AS lesion. AGO1 inhibition in oxPAPC-treated ECs demonstrated a profound anti-inflammatory effect, decreased ICAM1, VCAM1, MCP1 mRNA levels and monocyte adhesion. Additionally, a potential novel AGO1-mediated gene regulatory mechanism was identified at the molecular level through transcriptional induction. Conclusions: Our study identifies AGO1 as a key regulator in ECD, hyperlipidemia, and vascular inflammation, contributing to AS. Understanding the molecular mechanisms and functional significance of AGO1-regulated ECD provides valuable insights for novel therapeutic strategies to intervene in metabolic and cardiovascular diseases involving ECD.
Biology,Medicine
What problem does this paper attempt to address?